Ellen M. Lintal - 04 Apr 2022 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Role: Former Chief Financial Officer
Signature: Ellen Lintal
Issuer symbol: AIMI
Transactions as of: 04 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Jan 2023, 13:58:20 UTC
Previous filing: 04 Mar 2022
SEC: View on sec.gov

Ellen M. Lintal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

The reporting person retired on March 31, 2022. This Form 4 is being filed solely to check the box that the reporting person is no longer subject to Section 16 filings.